DelMar Pharmaceuticals, Inc.

DelMar Pharmaceuticals, Inc.verified

DMPWW

Price:

$0.0001

Market Cap:

$52.17M

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a stra...[Read more]

Industry

Biotechnology

IPO Date

Stock Exchange

OTC

Ticker

DMPWW

The Current Ratio as of December 2025 (TTM) for DelMar Pharmaceuticals, Inc. (DMPWW) is 0.83

According to DelMar Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.83. This represents a change of -35.77% compared to the average of 1.29 of the last 4 quarters.

DelMar Pharmaceuticals, Inc. (DMPWW) Historical Current Ratio (quarterly & annually)

How has DMPWW Current Ratio performed in the past?

The mean historical Current Ratio of DelMar Pharmaceuticals, Inc. over the last ten years is 3.84. The current 0.83 Current Ratio has changed 2.05% with respect to the historical average. Over the past ten years (40 quarters), DMPWW's Current Ratio was at its highest in in the September 2016 quarter at 10.40. The Current Ratio was at its lowest in in the September 2025 quarter at 0.

Quarterly (TTM)
Annual

Average

3.84

Median

3.96

Minimum

0.79

Maximum

10.07

DelMar Pharmaceuticals, Inc. (DMPWW) Current Ratio by Quarter and Year

Discovering the peaks and valleys of DelMar Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 546.13%

Maximum Annual Current Ratio = 10.07

Minimum Annual Increase = -81.27%

Minimum Annual Current Ratio = 0.79

Quarterly (TTM)
Annual
YearCurrent RatioChange
20243.68218.17%
20231.16-77.48%
20225.13546.13%
20210.79-81.27%
20214.24311.59%
20201.03-47.00%
20191.94-54.78%
20184.30-28.73%
20176.03-40.09%
201610.07324.26%

DelMar Pharmaceuticals, Inc. (DMPWW) Average Current Ratio

How has DMPWW Current Ratio performed in the past?

The current Current Ratio of DelMar Pharmaceuticals, Inc. (DMPWW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.32

5-year avg

3.00

10-year avg

3.84

DelMar Pharmaceuticals, Inc. (DMPWW) Current Ratio vs. Peers

How is DMPWW’s Current Ratio compared to its peers?

DelMar Pharmaceuticals, Inc.’s Current Ratio is greater than Kiromic BioPharma, Inc. (0.16), greater than Hemogenyx Pharmaceuticals Plc (0.72), greater than Vitalibis, Inc. (0.29), less than Evome Medical Technologies Inc. (0.87), less than ProSomnus, Inc. (1.00), greater than Advanced Proteome Therapeutics Corporation (0.50), greater than CuraScientific Corp (0.00), less than TRACON Pharmaceuticals, Inc. (0.89), less than Molecular Templates, Inc. (0.97), greater than Predictive Technology Group, Inc. (0.37),

Build a custom stock screener for DelMar Pharmaceuticals, Inc. (DMPWW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DelMar Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DelMar Pharmaceuticals, Inc. (DMPWW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DelMar Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is DelMar Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for DelMar Pharmaceuticals, Inc. (DMPWW)?

What is the highest Current Ratio for DelMar Pharmaceuticals, Inc. (DMPWW)?

What is the 3-year average Current Ratio for DelMar Pharmaceuticals, Inc. (DMPWW)?

What is the 5-year average Current Ratio for DelMar Pharmaceuticals, Inc. (DMPWW)?

How does the current Current Ratio for DelMar Pharmaceuticals, Inc. (DMPWW) compare to its historical average?